TrialPath

5 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Type 2 diabetes

    📍 UCSF Benioff Children's Hospital Oakland, Pediatric Diabetes Clinic · Oakland, CA · +1 more US site · Get directions →

    The purpose of this study to compare the typically prescribed dose of metformin (1000mg twice a day) with a higher dose of metformin (1350mg twice a day).

    ✓ Study care freeEarly Phase 1Ages 10–21Learn more →
  • Type 2 diabetesKidney disease

    📍 Brigham and Women's Hospital · Boston, MA · Get directions →

    The aim of this protocol is to assess the presence and severity of primary aldosteronism pathophysiology in patients with type 2 diabetes who have, or are at-risk for developing, chronic kidney disease.

    ✓ Study care freeEarly Phase 1Ages 18–80Learn more →
  • Type 2 diabetesHeart / cardiovascular disease

    📍 University of Texas Health Science Center at San Antonio · San Antonio, TX · Get directions →

    This study will provide insight into whether cardiac function changes with oral Ketone Esters (KE) administered to patients with Type 2 Diabetes Mellitus (T2DM) and Heart failure with reduced ejection fraction (HFrEF). Plasma ketones are avidly extracted by cardiac muscle and their uptake is not dependent upon insulin or influenced by insulin resistance.

    ✓ Study care freeEarly Phase 1Ages 18–80Learn more →
  • Type 2 diabetes

    📍 Medical College of Wisconsin · Milwaukee, WI · Get directions →

    The goal of this clinical trial is to examine the role of autophagy on microvascular function in adults with Type 2 Diabetes. The main question it aims to answer are: * Does presence of Type 2 Diabetes reduce autophagy and impair microvascular function?

    ✓ Study care freeEarly Phase 1Ages 18–80Learn more →
  • Type 2 diabetes

    📍 Texas Diabetes Institute/UH · San Antonio, TX · Get directions →

    In this study, PI will test the hypothesis that distinct mechanisms account for the SGLT2i-induced stimulation of ketogenesis and lipolysis versus endogenous (hepatic) glucose production in patients with type 2 diabetes (T2D) that the increases in ketone production and lipolysis can be prevented by concomitant administration of the thiazolidinedione pioglitazone. Principal Investigator (PI) will conduct five distinct experiments to test this hypothesis in patients with T2D.

    ✓ Study care freeEarly Phase 1Ages 30–75Learn more →